Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway von Rubinstein, Maria M., Hyman, David M., Caird, Imogen, Won, Helen, Soldan, Krysten, Seier, Kenneth, Iasonos, Alexia, Tew, William P., O’Cearbhaill, Roisin E., Grisham, Rachel N., Hensley, Martee L., Troso‐Sandoval, Tiffany, Sabbatini, Paul, Guillen, Joyce, Selcuklu, S. Duygu, Zimel, Catherine, Torrisi, Jean, Aghajanian, Carol, Makker, Vicky

Volltext

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study von Rubinstein, Maria M., Doria, Eric Rios, Konner, Jason, Lichtman, Stuart, Zhou, Qin, Iasonos, Alexia, Sarasohn, Debra, Troso-Sandoval, Tiffany, Friedman, Claire, O'Cearbhaill, Roisin, Cadoo, Karen, Kyi, Chrisann, Cohen, Seth, Soldan, Krysten, Billinson, Eric, Caird, Imogen, Jang, Dasom, Eid, Khalil, Shah, Pooja, Guillen, Joyce, Aghajanian, Carol, Zamarin, Dmitriy, Makker, Vicky

Volltext

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers von Rubinstein, Maria M., Grisham, Rachel N., Cadoo, Karen, Kyi, Chrisann, Tew, William P., Friedman, Claire F., O'Cearbhaill, Roisin E., Zamarin, Dmitriy, Zhou, Qin, Iasonos, Alexia, Nikolovski, Ines, Xu, Hongmei, Soldan, Krysten N., Caird, Imogen, Martin, Madhuri, Guillen, Joyce, Eid, Khalil T., Aghajanian, Carol, Makker, Vicky

Volltext

Abstract B18: Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer von Rubinstein, Maria M., Hyman, David, Caird, Imogen, O'Cearbhaill, Roisin, Grisham, Rachel, Tew, William, Hensley, Martee, Sabbatini, Paul, Aghajanian, Carol, Iasonos, Alexia, Won, Helen, Selcuklu, Duygu, Zimel, Catherine, Makker, Vicky

Volltext

Phase II Study of LY3023414 in Patients with Advanced Endometrial Cancer Harboring Activating Mutations in the PI3K Pathway von Rubinstein, Maria M., Hyman, David M., Caird, Imogen, Won, Helen, Soldan, Krysten, Seier, Kenneth, Iasonos, Alexia, Tew, William P., O’Cearbhaill, Roisin E., Grisham, Rachel N., Hensley, Martee L., Troso-Sandoval, Tiffany, Sabbatini, Paul, Guillen, Joyce, Selcuklu, S. Duygu, Zimel, Catherine, Torrisi, Jean, Aghajanian, Carol, Makker, Vicky

Volltext

A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma von Rubinstein, Maria M, Caird, Imogen, Zhou, Qin, Iasonos, Alexia, Friedman, Claire Frances, Cadoo, Karen Anne, Konner, Jason A., O'Cearbhaill, Roisin Eilish, Tew, William P., Zamarin, Dmitriy, Grisham, Rachel N., Kyi, Chrisann, Soldan, Krysten, Lichtman, Stuart M., Ligresti, Louise, Schweber, Sarah J., Singh, Jasmeet Chadha, Troso-Sandoval, Tiffany A., Aghajanian, Carol, Makker, Vicky

Volltext